 MENLO PARK, Calif., June 28, 2021 GLOBE NEWSWIRE -- 180 Life Sciences Corp. NASDAQ: ATNF 180 Life Sciences or the Company, a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, announced today that it has joined the Russell Microcap Index, effective after the U.S. market opens today, June 28. 